AJMC Staff

Open enrollment for ACA health plans is extended after glitches on Healthcare.gov; EPA watchdog found that the agency's health monitoring during Hurricane Harvey was lacking; Purdue Pharma splits ties with the lobbying organization PhRMA.

BMS and Gilead continue their fight over Yescarta patent infringement; Canadian researchers develop multidrug-resistant, bacteria-repelling plastic coating; Healthcare.gov floods with last-minute sign-ups on final day of enrollment for 2020 plans.

A study presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, Florida, discussed the first report of next-generation sequencing (NGS) to test for minimal disease response (MRD) after the combination of ibrutinib plus fludarabine, cyclophosphamide, and rituximab (iFCR) in chronic lymphocytic leukemia (CLL).

More treatments are needed for the 100 million individuals worldwide affected by psoriasis. Researchers from Brigham and Women's Hospital and the Harvard Stem Cell Institute have discovered a possible source of the skin thickening that may be triggered by dysregulated stem cells.

Speaker Nancy Pelosi’s, D-California, drug bill passes in the House; the FDA approves Vyondys 53, from Sarepta Therapeutics, to treat Duchenne muscular dystrophy; San Francisco tackles homelessness, mental illness, and substance abuse.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

The HHS’ Office of the Inspector General (OIG) released a report that says Medicare Advantage (MA) plans received an estimated $6.7 billion in 2017 after adding diagnoses to patients' files that were not supported by their medical records; more Americans are dying at home rather than in hospitals or nursing homes; the FDA warned Alkermes, maker of Vivitrol, a long-acting antiaddiction medication, that its printed advertisement does not include the risk of an increased chance of a “potentially fatal” opioid overdose as the effects wear off.

Sanofi is ending research efforts in diabetes and cardiovascular diseases; the White House endorsed an emerging bipartisan agreement on legislation aimed at curbing rising healthcare costs by targeting surprise medical billing; the Supreme Court will hear oral arguments in a case involving whether the federal government owes insurers $12 billion in a dispute about risk corridor payments.

A proposed ban on surprise medical bills has growing bipartisan support; Republicans are set to propose a drug pricing bill to compete with Democrats; vaping-related illnesses are on the decline.

There are significant sex differences in links between psoriasis and metabolic disorders, according to a study published this week.

Results of the study indicated that irregular schedules, increased night shifts, sleep disturbances, and work hours were related to a higher burnout risk in police officers.

The findings show the importance of preventing bone disease in multiple myeloma (MM), the authors said.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Activists seek to block Gilead’s patent extension for HIV drug tenofovir alafenamide; 2.1 million teens are using 1 or more tobacco products; African American and low-income mothers are less likely to seek treatment for postpartum depression.

The Trump adminsitration plans to tighten work requirements for food stamp recipients, potentially leaving 688,000 without coverage; Virginia moves to suspend Medicaid work requirements; hair dye and hair straighteners were linked to an increased risk of breast cancer in a new study.

California hands down millions in fines to Anthem Blue Cross; “street medicine” aims to bring healthcare to the homeless in Atlanta; Johnson & Johnson claims its baby powder is safe.

Acute stress was found to be a possible trigger following the loss of a partner, but not a factor in long-term risk for either disorder.

The US Supreme Court was given 2 amicus briefs by legal, medical groups advocating against the Louisiana abortion law; Michigan's governor calls to pause impending Medicaid work requirements; emergency medical service crews in Rhode Island shown to misplace breathing tubes in patients, leading to death.

A high-tech drug testing machine is being utilized to detect fentanyl in illicit drugs; the Massachusetts governor enacts a stingent vaping flavor ban; data on blood-sugar levels for patients with diabetes using Dexcom's continuous glucose monitor (CGM) has been unavailable since Saturday.

Tumor slices provide a useful platform for studying the tumor microenvironment and evaluating the preclinical efficacy of cancer therapeutics, according to a recent study.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Hospitals in California are facing critical decisions on patient care; the FDA and CDC are investigating a multistate hepatitis A outbreak; 6 pharmaceutical giants are being investigated for their potential roles in the opioid crisis.

US Customs and Border Protection rejected recommendations by the CDC to vaccinate migrants in detention centers for the flu; PhRMA cut its donation to Addiction Policy Forum and will end all support in 2020; Louisiana health officials announced they will examine the cancer incidence in an area next to a chemical plant known to emit a likely carcinogen.

Novartis AG announced their purchase agreement with cholesterol drugmaker Medicines Company; Trump is set to allow state importation of prescription drugs to curb rising drug prices; flu shot efficacy was found to be worse in people who are overwight, obese.

Researchers in North Carolina reported discoveries that may lead to further understandings about how pancreatic cancer can become resistant to treatment.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

New Massachusetts legislation bans the sale of menthol products; a group of hospitals is suing HHS; the FDA has approved a new treatment for partial-onset seizures.

Regardless of the government's removal of cost and access obstacles to flu vaccinations, adherence remains stagnant; multistate hepatitis A outbreak linked to blackberries sold in grocery store chain; President Trump's FDA nominee Stephen Hahn avoids talk on the suspended e-cig flavor ban during his Senate confirmation hearing.

A House committee approves a bill to ban all flavored tobacco products; anal cancer rates are on the rise; the debate continues over competing healthcare measures.

California is suing Juul Labs for their role in the youth vaping crisis; a lack of clean water and plumbing was shown to disproportionately affect Native Americans; a chemical plant is passing the permit process in a Louisiana area already dubbed “cancer alley.”